RT Generic
T1 Ensayo clínico aleatorizado, ciego y placebo controlado sobre el uso de profilaxis antibiótica en la prevención de la infección postoperatoria de terceros molares mandibulares impactados. Un estudio piloto
A1 Montaner, Nicolás Yanine
AB Objetivo: Determinar la utilidad de la administración de profilaxis antibiótica (PA) para la prevención de complicaciones infecciosas e inflamatorias en la cirugía de terceros molares mandibulares impactados y mesioangulados (TMMim) y verificar la factibilidad de llevar a cabo un protocolo de investigación bajo condiciones ideales, aportando información para un posterior estudio. Diseño del Estudio: Ensayo clínico aleatorizado piloto, ciego y placebo controlado. Materiales y Métodos: 34 pacientes fueron aleatorizados en 2 grupos de 17 pacientes. Al grupo experimental se le administró 2 gramos de amoxicilina 1 hora antes de la intervención, mientras que al grupo control se le administró 2 comprimidos placebo en las mismas condiciones. Los pacientes fueron controlados a los 3, 7 y 30 días. Resultados: Del grupo placebo 1 paciente presentó una complicación infecciosa (alveolitis), mientras que en el grupo experimental ningún paciente presentó infección. (p>0.05) Sin embargo, hubo diferencias significativas en la necesidad de analgesia de rescate en el grupo placebo. (p<0.05) Conclusiones: Los resultados obtenidos en este ensayo clínico piloto determinaron que el uso de amoxicilina 2 gramos una hora antes de la cirugía no es efectiva en la prevención de complicaciones infecciosas postquirúrgicas de TMMim, pero sí disminuyen la necesidad de analgesia de rescate. El presente estudio demostró tener un protocolo factible de realizar en un ensayo clínico definitivo, cuyo tamaño muestral debería alcanzar 362 pacientes sanos con TMMim, para lograr una potencia estadística satisfactoria.
YR 2011
FD 2011
LK https://hdl.handle.net/20.500.14352/46621
UL https://hdl.handle.net/20.500.14352/46621
LA spa
NO 1. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital infection control practices advisory committee. Infect Control Hosp Epidemiol. 1999;20:250-278; quiz 279-2802. Munckhof W. Antibiotics for surgical prophylaxis Aust Prescr. 2005;28:38-403. Salmeron-Escobar JI, del Amo-Fernandez de Velasco A. Antibiotic prophylaxis in oral and maxillofacial surgery. Med Oral Patol Oral Cir Bucal. 2006;11:E292-2964. Ren YF, Malmstrom HS. Effectiveness of antibiotic prophylaxis in third molar surgery: A meta-analysis of randomized controlled clinical trials. J Oral Maxillofac Surg. 2007;65:1909-19215. Arteagoitia I, Diez A, Barbier L, Santamaria G, Santamaria J. Efficacy of amoxicillin/clavulanic acid in preventing infectious and inflammatory complications following impacted mandibular third molar extraction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:e11-186. Halpern LR, Dodson TB. Does prophylactic administration of systemic antibiotics prevent postoperative inflammatory complications after third molar surgery? J Oral Maxillofac Surg. 2007;65:177-1857. Poeschl PW, Eckel D, Poeschl E. Postoperative prophylactic antibiotic treatment in third molar surgery--a necessity? J Oral Maxillofac Surg. 2004;62:3-8; discussion 98. Kaczmarzyk T. Abuse of antibiotic prophylaxis in third molar surgeries. J Oral Maxillofac Surg. 2009;67:2551-25529. Monaco G, Tavernese L, Agostini R, Marchetti C. Evaluation of antibiotic prophylaxis in reducing postoperative infection after mandibular third molar extraction in young patients. J Oral Maxillofac Surg. 2009;67:1467-147210. Limeres J, Sanroman JF, Tomas I, Diz P. Patients' perception of recovery after third molar surgery following postoperative treatment with moxifloxacin versus amoxicillin and clavulanic acid: A randomized, double-blind, controlled study. J Oral Maxillofac Surg. 2009;67:286-29111. Kaczmarzyk T, Wichlinski J, Stypulkowska J, Zaleska M, Panas M, Woron J. Single-dose and multi-dose clindamycin therapy fails to demonstrate efficacy in preventing infectious and inflammatory complications in third molar surgery. Int J Oral Maxillofac Surg. 2007;36:417-42212. Ataoglu H, Oz GY, Candirli C, Kiziloglu D. Routine antibiotic prophylaxis is not necessary during operations to remove third molars. Br J Oral Maxillofac Surg. 2008;46:133-13513. Lacasa JM, Jimenez JA, Ferras V, Bossom M, Sola-Morales O, Garcia-Rey C, Aguilar L, Garau J. Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: A randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg). Int J Oral Maxillofac Surg. 2007;36:321-32714. Yoshii T, Hamamoto Y, Muraoka S, Furudoi S, Komori T. Differences in postoperative morbidity rates, including infection and dry socket, and differences in the healing process after mandibular third molar surgery in patients receiving 1-day or 3-day prophylaxis with lenampicillin. J Infect Chemother. 2002;8:87-9315. Bulut E, Bulut S, Etikan I, Koseoglu O. The value of routine antibiotic prophylaxis in mandibular third molar surgery: Acute-phase protein levels as indicators of infection. J Oral Sci. 2001;43:117-12216. Sekhar CH, Narayanan V, Baig MF. Role of antimicrobials in third molar surgery: Prospective, double blind,randomized, placebo-controlled clinical study. Br J Oral Maxillofac Surg. 2001;39:134-13717. Friedman JW. The prophylactic extraction of third molars: A public health hazard. Am J Public Health. 2007;97:1554-155918. Laskin DM. The use of prophylactic antibiotics for the prevention of postoperative infections. Oral Maxillofac Surg Clin North Am. 2003;15:155-16019. Kuriyama T, Karasawa T, Nakagawa K, Saiki Y, Yamamoto E, Nakamura S. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:600-60820. Rega AJ, Aziz SR, Ziccardi VB. Microbiology and antibiotic sensitivities of head and neck space infections of odontogenic origin. J Oral Maxillofac Surg. 2006;64:1377-138021. Miloro M. Peterson’s principles of oral and maxillofacial surgery. 2nd Edition. Volume I. Hamilton, On: BC Decker Inc;. 2004:P. 14022. Gay C. Cirugía bucal. 1ra edición. Ediciones Argon. 1999;367:371-37223. Normark BH, Normark S. Evolution and spread of antibiotic resistance. J Intern Med. 2002;252:91-10624. Lockhart PB, Brennan MT, Fox PC, Norton HJ, Jernigan DB, Strausbaugh LJ. Decision-making on the use of antimicrobial prophylaxis for dental procedures: A survey of infectious disease consultants and review. Clin Infect Dis. 2002;34:1621-162625. Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010;10:6726. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, Robson R, Thabane M, Giangregorio L, Goldsmith CH. A tutorial on pilot studies: The what, why and how. BMC Med Res Methodol. 2010;10:127. Baqain ZH, Karaky AA, Sawair F, Khraisat A, Duaibis R, Rajab LD. Frequency estimates and risk factors for postoperative morbidity after third molar removal: A prospective cohort study. J Oral Maxillofac Surg. 2008;66:2276-228328. Chuang SK, Perrott DH, Susarla SM, Dodson TB. Age as a risk factor for third molar surgery complications. J Oral Maxillofac Surg. 2007;65:1685-169229. Schulz KF, Altman DG, Moher D. Consort 2010 statement: Updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010;7:e100025130. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K. A pragmatic-explanatory continuum indicator summary (precis): A tool to help trial designers. CMAJ. 2009;180:E47-57
DS Docta Complutense
RD 3 may 2024